As MYC signaling is necessary for the expression of C9orf16 and cancer development, we then attempted to block MYC signaling pathway by two commonly used small molecular inhibitors, MYRA-A and KSI-3716 [51, 52]. The gene discussed is BBLN; the disease is cancer.